Similar articles for PMID: 10321752

Year	Number of Results
1991	2
1993	1
1994	6
1995	3
1996	6
1997	4
1998	8
1999	10
2000	8
2001	8
2002	7
2003	5
2004	5
2005	4
2006	4
2007	3
2008	1
2009	2
2010	1
2011	3
2012	2
2013	1
2016	2
2017	1
2020	1
2024	0

1

Toxicity of NSAIDs in the stomach and duodenum.

Lanas A, Hirschowitz BI. Lanas A, et al. Eur J Gastroenterol Hepatol. 1999 Apr;11(4):375-81. doi: 10.1097/00042737-199904000-00003. Eur J Gastroenterol Hepatol. 1999. PMID: 10321752 Review.

2

Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.

Graham DY. Graham DY. Am J Med. 2001 Jan 8;110(1A):58S-61S. doi: 10.1016/s0002-9343(00)00644-6. Am J Med. 2001. PMID: 11166000 Review.

3

Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.

Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I. Bianchi Porro G, et al. Gut. 1996 Jul;39(1):22-6. doi: 10.1136/gut.39.1.22. Gut. 1996. PMID: 8881802 Free PMC article. Clinical Trial.

4

[Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].

Chinese Rheumatism Data Center; Chinese Systemic Lupus Erythematosus Treatment and Research Group. Chinese Rheumatism Data Center, et al. Zhonghua Nei Ke Za Zhi. 2017 Jan 1;56(1):81-85. doi: 10.3760/cma.j.issn.0578-1426.2017.01.021. Zhonghua Nei Ke Za Zhi. 2017. PMID: 28056333 Chinese.

5

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: a case-control study.

Aalykke C, Lauritsen JM, Hallas J, Reinholdt S, Krogfelt K, Lauritsen K. Aalykke C, et al. Gastroenterology. 1999 Jun;116(6):1305-9. doi: 10.1016/s0016-5085(99)70494-4. Gastroenterology. 1999. PMID: 10348813

6

Nonsteroidal anti-inflammatory drugs and the gut.

Hirschowitz BI. Hirschowitz BI. South Med J. 1996 Mar;89(3):259-63. doi: 10.1097/00007611-199603000-00001. South Med J. 1996. PMID: 8604453 Review.

7

Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.

Lanas AI. Lanas AI. Am J Med. 2001 Jan 8;110(1A):70S-73S. doi: 10.1016/s0002-9343(00)00647-1. Am J Med. 2001. PMID: 11166003

8

[Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].

Limmer S, Ittel TH, Wietholtz H. Limmer S, et al. Z Gastroenterol. 2003 Aug;41(8):719-28. doi: 10.1055/s-2003-41208. Z Gastroenterol. 2003. PMID: 12910426 Review. German.

9

Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.

Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P. Voutilainen M, et al. Scand J Gastroenterol. 2001 Aug;36(8):817-21. doi: 10.1080/003655201750313333. Scand J Gastroenterol. 2001. PMID: 11495076

10

Helicobacter pylori infection and the use of NSAIDs.

Bazzoli F, De Luca L, Graham DY. Bazzoli F, et al. Best Pract Res Clin Gastroenterol. 2001 Oct;15(5):775-85. doi: 10.1053/bega.2001.0234. Best Pract Res Clin Gastroenterol. 2001. PMID: 11566040 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year